What are the uses and dosages of Diamox (acetazolamide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diamox (Acetazolamide): Clinical Uses and Dosing

Acetazolamide is a carbonic anhydrase inhibitor with FDA-approved indications for glaucoma, epilepsy, congestive heart failure, and drug-induced edema, with established off-label uses for altitude sickness prevention and idiopathic intracranial hypertension. 1

FDA-Approved Indications and Dosing

Glaucoma

  • Chronic open-angle glaucoma: 250 mg to 1 g per 24 hours in divided doses (amounts >250 mg should be divided); dosages exceeding 1 g per 24 hours typically do not produce increased effect 1
  • Secondary glaucoma and acute closed-angle glaucoma: 250 mg every 4 hours, though some cases respond to 250 mg twice daily 1
  • Acute cases: Initial 500 mg followed by 125-250 mg every 4 hours; IV therapy may be used for rapid relief of ocular tension 1

Epilepsy

  • Pediatric and adult dosing: 8-30 mg/kg/day in divided doses, with optimal range 375-1000 mg daily 1
  • Starting dose when adding to existing anticonvulsants: 250 mg once daily, then titrate upward 1
  • Best results seen in petit mal seizures in children, though effective in grand mal and other seizure patterns 1

Congestive Heart Failure (Diuresis)

  • Starting dose: 250-375 mg once daily in the morning (5 mg/kg) 1
  • Optimal regimen: Alternate-day dosing or 2 days on/1 day off to allow kidney recovery 1
  • If edema fluid loss stops, skip medication for a day rather than increasing dose 1

Drug-Induced Edema

  • Dosing: 250-375 mg once daily for 1-2 days, alternating with a day of rest 1

Key Off-Label Uses

Altitude Sickness Prevention

  • Standard prophylactic dose: 250 mg twice daily or 500 mg once daily 2
  • Lower effective dose: 125 mg twice daily (250 mg/day total) has similar efficacy with potentially fewer side effects 2
  • For rapid ascent >3,500 m (military/emergency personnel): 500-750 mg/day appears most effective 3
  • Timing: Start 1-3 days prior to ascent and continue for 3-4 days after reaching terminal altitude 2
  • Mechanism: Induces metabolic acidosis that stimulates respiratory drive, improves arterial oxygen saturation (88-91% at altitude), and reduces periodic breathing 2

Important caveat: Acetazolamide 62.5 mg twice daily failed noninferiority testing and should NOT be recommended, with a number needed to harm of 9 compared to 125 mg twice daily 4

Idiopathic Intracranial Hypertension (IIH)

  • Starting dose: 250-500 mg twice daily, with majority of clinicians titrating upward 5
  • Maximum studied dose: 4 g daily (only 44% of patients tolerate this dose) 5
  • Typical tolerated dose: 1-1.5 g daily (48% discontinue at mean 1.5 g/day due to side effects) 5, 6
  • Pediatric dosing: Initial 25 mg/kg/day, titrate to clinical response (maximum 100 mg/kg/day) 6

Critical limitation: Acetazolamide has NOT been shown effective for headache treatment alone in IIH 5, 6

Obstructive Sleep Apnea (Research Setting Only)

  • Dose range studied: 36-1000 mg daily for up to 3 months 6
  • Effect: Reduces apnea-hypopnea index by up to 45% and improves oxygen saturation 6
  • Guideline position: European Respiratory Society recommends use only in research settings, not routine clinical practice 6

Side Effect Profile and Management

Most Common Side Effects (Dose-Dependent)

  • Paraesthesias: Occur in approximately 1 in 2-3 patients (number needed to harm = 2.3); risk increases significantly with higher doses 6, 7
  • Dysgeusia (taste disturbance): 1 in 18 patients; dose-dependent 6, 7
  • Fatigue: 1 in 11 patients; trend toward dose-dependence 6, 7
  • Polyuria: Number needed to harm = 17 7
  • Tinnitus, nausea, vomiting, diarrhea: Well-documented 5, 6
  • Cognitive slowing and depression: Particularly concerning for patients requiring mental acuity 5, 6

Serious Adverse Effects

  • Renal stones: Rare but recognized complication 5, 6
  • Electrolyte imbalances (hypokalemia): Requires monitoring 6, 8
  • Metabolic acidosis: Can occur, particularly in overdose 6

Contraindications and Special Populations

  • Pregnancy: Contraindicated due to teratogenic risks 6
  • Renal impairment: Dosing should not be more frequent than every 12 hours if creatinine clearance <50 mL/min 9
  • Sulfonamide allergy: Acetazolamide is a sulfonamide derivative 9
  • Diabetic patients: Monitor electrolytes and blood glucose; consider metabolic effects carefully 8

Practical Prescribing Strategy

Minimizing Side Effects

  • Start low and go slow: Begin with 250-500 mg twice daily and titrate gradually 5, 6
  • Consider lower doses for altitude sickness: 125 mg twice daily is effective with fewer side effects than higher doses 2
  • Avoid excessive dosing: Higher doses increase side effect burden without proportional benefit in many conditions 5, 1

Monitoring Requirements

  • Electrolytes: Monitor for hypokalemia, particularly in diabetic patients 6, 8
  • Renal function: Adjust dosing frequency with impaired creatinine clearance 9
  • Clinical response: In IIH, 48% discontinue due to side effects at mean 1.5 g/day 6

Route of Administration

  • Oral preferred for most indications 1
  • IV route: Preferred for parenteral administration when needed (acute glaucoma, rapid ICP reduction) 1
  • IM route: Not recommended 1

References

Guideline

Acetazolamide for Altitude Sickness Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acetazolamide Side Effects and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Considerations for Carbonic Anhydrase Inhibitors in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluating off-label uses of acetazolamide.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.